Cubist Pharmaceuticals

Pfizer Blockbuster Zyvox Under Attack

Pfizer Blockbuster Zyvox Under Attack

Motley Fool

FDA panel says Cubist anti-infective shows efficacy, safety

FDA panel says Cubist anti-infective shows efficacy, safety

Yahoo/Reuters

Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals

Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals

Yahoo/Zacks.com

3 Upcoming FDA Meetings You Should be Watching

3 Upcoming FDA Meetings You Should be Watching

Motley Fool

Ten Top Biotech Merger and Partnership Candidates

Ten Top Biotech Merger and Partnership Candidates

Wall St 24/7

Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin

Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin

Seeking Alpha

Will Cubist Pharma (CBST) Miss Earnings?

Will Cubist Pharma (CBST) Miss Earnings?

Yahoo/Zacks.com

Tetraphase Pharmaceuticals: A Small Cap With Big Potential

Tetraphase Pharmaceuticals: A Small Cap With Big Potential

Seeking Alpha

FDA starts review of Cubist Pharma antibiotic

FDA starts review of Cubist Pharma antibiotic

Yahoo/AP

Click here to subscribe to daily news headlines in your email inbox